Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Psilocybin

Man amputates penis with an axe after consuming psilocybin mushrooms

by Eric W. Dolan
September 29, 2024
in Psilocybin
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Don't miss out! Follow PsyPost on Bluesky!

In an unprecedented case report, doctors in Austria have documented the first known instance of psilocybin-induced penile amputation. After consuming a large quantity of magic mushrooms, a 37-year-old man suffering from depression and alcohol abuse severed his penis with an axe. Fortunately, doctors were able to reattach part of the amputated organ. The unique case is detailed in the Mega Journal of Surgery.

Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, often referred to as “magic mushrooms.” When ingested, the compound is broken down in the body to produce psilocin, a substance that affects serotonin receptors in the brain. This can lead to a variety of mind-altering experiences, including hallucinations, changes in perception of time, and intense emotional shifts. The use of psilocybin has a long history, dating back to ancient cultures that used it for religious or spiritual purposes.

Today, psilocybin is gaining attention in medical research due to its potential therapeutic benefits. Scientists are investigating its use in treating conditions like depression, anxiety, and post-traumatic stress disorder. In particular, studies have shown promising results for psilocybin’s ability to alleviate symptoms in people with major depressive disorder, even when other treatments have failed.

In addition to its therapeutic potential, psilocybin is of interest to neuroscientists for what it reveals about the brain’s inner workings. By studying how psilocybin disrupts and alters normal brain function, researchers can gain insights into how the brain produces consciousness, processes emotions, and constructs a sense of self. These findings have the potential to improve our understanding of various mental health conditions and open new pathways for treatment.

However, while psilocybin has shown promise in clinical settings, its use outside of these controlled environments can lead to dangerous outcomes. The case described in Austria is a stark reminder that, in certain circumstances, psilocybin can provoke extreme psychological responses, particularly when taken in high doses or by individuals with a history of mental health issues.

The case report published by doctors at Hospital Feldkirch in Austria outlines the shocking details of a 37-year-old man who consumed a large dose of psilocybin and, during a severe psychotic episode, amputated his penis using an axe. The man, who had a history of depression and alcohol abuse, ingested four or five dried psilocybin mushrooms while staying alone in a secluded vacation home.

Not long after consuming the mushrooms, the man began to experience a terrifying hallucination or delusion, which led him to take an axe and sever his penis into multiple pieces. The details of the event are unclear to the patient, as he did not fully remember what had occurred.

The man reportedly tied a piece of cloth around his genital area to control the bleeding and placed the severed parts of his penis in a jar filled with snow. He then left the house, bleeding profusely, in search of help. A passerby found him in a confused state and called for emergency services. The man was transported to a nearby village and later to a hospital, arriving approximately five hours after the amputation.

Upon arrival, the patient was in a critical condition, having lost a significant amount of blood. He was immediately taken into surgery, where doctors worked to stabilize him and control the bleeding. His penis was contaminated with soil and snow, and parts of the organ were severely damaged. Surgeons were able to save the glans (the tip of the penis) and about two centimeters of the penile shaft, but the other sections were too damaged to be repaired.

Remarkably, the replantation was successful, despite the significant challenges posed by the extent of the injury and contamination. Despite initial difficulties, the patient’s condition improved after the surgery, although he continued to suffer from severe psychotic symptoms, including auditory hallucinations and religious delusions. He was placed under psychiatric care, and his treatment included antipsychotic medications to help control the hallucinations. His mental state gradually stabilized, and after a week, he was moved back to the urology department to continue his recovery.

In the weeks following the surgery, the patient experienced some complications. Superficial necrosis (death of skin tissue) developed on the glans of his penis, likely due to the loss of blood flow during the period of ischemia, but this healed over time. Remarkably, the patient was able to regain some erectile function within three months of the surgery, though the overall length of his penis was significantly reduced due to the damage. At his last follow-up visit, he was able to urinate normally while seated, though a minor complication called hypospadias developed, where the urethral opening is located further down the shaft than normal.

While this case is the first documented instance of psilocybin-induced self-amputation, it brings attention to a broader phenomenon of self-mutilation during psychotic episodes, particularly among individuals with underlying mental health conditions. Known as Klingsor syndrome, these rare but extreme events often involve self-inflicted injury to the genitals and can be associated with a range of psychiatric conditions, from schizophrenia to substance-induced psychosis.

Case reports are typically used by doctors and researchers to document unusual or rare medical events. They offer valuable real-world examples of how certain drugs, treatments, or conditions can manifest in unique circumstances. However, because case reports usually focus on a single patient, they do not provide the kind of broad, statistically significant data that is needed to establish definitive conclusions about a drug or condition.

In other words, while this case demonstrates that psilocybin can, in rare instances, lead to severe psychotic episodes and self-harm, it does not mean that this outcome is common or likely to happen in most people who use psilocybin. In fact, the majority of research on psilocybin has shown that the drug is relatively safe when used in controlled environments with professional supervision.

Despite their limitations, case reports play a critical role in advancing medical knowledge. They help doctors identify rare side effects, potential risks, and best practices for managing complex cases. In the case of psilocybin, reports like this one could influence future guidelines for its therapeutic use and highlight the need for careful screening of patients before administering psychedelic treatments.

The case report, “Penile Replantation after Self-Amputation Following Psilocybin-Induced Drug Psychosis,” was authored by Andreas P. Berger and and Alfred Hobisch.

TweetSendScanShareSendPinShareShareShare

RELATED

Relaxation — not mystical experiences — emerges as best predictor of psychedelic therapy’s impact in surprising new study
LSD

Relaxation — not mystical experiences — emerges as best predictor of psychedelic therapy’s impact in surprising new study

November 8, 2024

Recent research found that psychedelic-assisted therapy reduced depressive symptoms, with relaxation during sessions being the strongest predictor of improvement.

Read more
Does psilocybin really provide long-term relief from depression, as new study suggests?
Psilocybin

Does psilocybin really provide long-term relief from depression, as new study suggests?

November 7, 2024

Psilocybin may improve mood, social functioning, and life meaning in depression, comparable to escitalopram over six months, but small sample size and other treatments limit conclusions; further research is needed to confirm long-term effectiveness.

Read more
Single-dose psilocybin therapy shows promise for veterans with treatment-resistant depression
Psilocybin

Single-dose psilocybin therapy shows promise for veterans with treatment-resistant depression

November 5, 2024

A single dose of psilocybin significantly reduced depression symptoms in many U.S. veterans with treatment-resistant depression, with 60% showing improvement at three weeks. However, effects varied, and some experienced limited relief, highlighting the need for further research.

Read more
Antidepressants may diminish psilocybin’s effects even after discontinuation
Psilocybin

Majority of Americans support supervised use of psilocybin for mental health and well-being

November 2, 2024

A new study reveals strong bipartisan support for supervised psilocybin use in both therapy and well-being enhancement, suggesting Americans are open to expanding access to psychedelics, with careful regulation, for mental health and personal growth.

Read more
Is the “trip” crucial for psychedelic therapy’s effectiveness? New research sheds light on its role in healing
Ketamine

Is the “trip” crucial for psychedelic therapy’s effectiveness? New research sheds light on its role in healing

October 11, 2024

A new study suggests that the subjective experiences of psychedelics like ketamine and psilocybin modestly contribute to their therapeutic effects, particularly for depression and substance use disorder.

Read more
Neuroscience research sheds light on how psilocybin alters spatial awareness
Neuroimaging

Neuroscience research sheds light on how psilocybin alters spatial awareness

October 9, 2024

Researchers found that psilocybin disrupts spatial memory in mice by reducing the stability and coordination of neurons in the retrosplenial cortex, offering new insights into the brain mechanisms behind the disorientation experienced during psychedelic trips.

Read more
Psilocybin may offer fast and lasting antidepressant benefits by enhancing brain plasticity
Psilocybin

Psilocybin may offer fast and lasting antidepressant benefits by enhancing brain plasticity

October 1, 2024

A new study shows that psilocybin promotes rapid and lasting antidepressant effects in mice by enhancing brain plasticity, suggesting its potential as a fast-acting treatment for depression, though further research in humans is needed.

Read more
Psychedelic mushroom extract may offer enhanced brain benefits over synthetic psilocybin
Psilocybin

Psilocybin boosts mind perception but doesn’t reduce atheism

September 25, 2024

A study found that while psilocybin increased mind perception of living and non-living entities, it did not significantly change participants' Atheist-Believer status or core metaphysical beliefs, contradicting earlier suggestions of increased spirituality post-psychedelic use.

Read more

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

RECENT

Female competition stress linked to disordered eating across the lifespan

Ketamine study unearths surprising insights into PTSD, emotion regulation, and dissociation

Genetic analysis reveals role of melatonin in ADHD symptom severity

Scientists discover atypical brain connectivity in those with alcohol use disorder

Cyberbullying linked to extreme dieting and cosmetic surgery interests in teen girls

The dark dating strategies “Red Pill” men use, according to their exes

Interdependent well-being in couples: evidence from American and Japanese spouses

Economic development strengthens gender stereotypes on career and family, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy